A detailed history of Wellington Management Group LLP transactions in Dexcom Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 5,698,514 shares of DXCM stock, worth $432 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,698,514
Previous 5,331,458 6.88%
Holding current value
$432 Million
Previous $604 Million 36.82%
% of portfolio
0.07%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $23.5 Million - $42.6 Million
367,056 Added 6.88%
5,698,514 $382 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $61.8 Million - $78.7 Million
560,565 Added 11.75%
5,331,458 $604 Million
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $545 Million - $668 Million
4,770,893 New
4,770,893 $662 Million
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $284 Million - $467 Million
3,762,962 New
3,762,962 $467 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $44 Million - $70.5 Million
-511,219 Reduced 10.32%
4,442,600 $414 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $86.4 Million - $101 Million
768,128 Added 18.35%
4,953,819 $637 Million
Q1 2023

May 12, 2023

SELL
$104.0 - $122.92 $14.7 Million - $17.4 Million
-141,424 Reduced 3.27%
4,185,691 $486 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $401 Million - $579 Million
-4,719,894 Reduced 52.17%
4,327,115 $490 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $252 Million - $311 Million
3,297,715 Added 57.36%
9,047,009 $729 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $316 Million - $618 Million
4,649,846 Added 422.93%
5,749,294 $428 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $55.3 Million - $76.5 Million
587,855 Added 114.91%
1,099,448 $562 Million
Q4 2021

Feb 11, 2022

SELL
$129.87 - $162.82 $61.3 Million - $76.9 Million
-472,219 Reduced 48.0%
511,593 $275 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $13 Million - $17.4 Million
-121,570 Reduced 11.0%
983,812 $538 Million
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $2.86 Million - $3.81 Million
-35,344 Reduced 3.1%
1,105,382 $472 Million
Q1 2021

May 17, 2021

SELL
$84.79 - $104.74 $1.12 Million - $1.38 Million
-13,179 Reduced 1.14%
1,140,726 $410 Million
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $30.7 Million - $41.2 Million
393,832 Added 51.82%
1,153,905 $427 Million
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $11.4 Million - $13.4 Million
-119,028 Reduced 13.54%
760,073 $313 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $43.8 Million - $73.6 Million
-699,007 Reduced 44.29%
879,101 $356 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $1.74 Million - $2.76 Million
36,470 Added 2.37%
1,578,108 $425 Million
Q4 2019

Feb 11, 2020

BUY
$36.62 - $57.29 $56.5 Million - $88.3 Million
1,541,638 New
1,541,638 $337 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.